SEARCH

SEARCH BY CITATION

References

  • 1
    Varotti G, Grazi GL, Vetrone G et al. Causes of early acute graft failure after liver transplantation: Analysis of a 17-year single-center experience. Clin Transplant 2005; 19: 492500.
  • 2
    Ploeg RJ, D'Alessandro AM, Knechtle SJ et al. Risk factors for primary dysfunction after liver transplantation: A multivariate analysis. Transplantation 1993; 55: 807813.
  • 3
    Farmer DG, Amersi F, Kupiec-Weglinski JW, Busuttil RW. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14: 10626.
  • 4
    Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002; 74: 522526.
  • 5
    Gilligan BJ, Woo HM, Kosieradzki M, Torrealba JR, Southard JH, Mangino MJ. Prolonged hypothermia causes primary nonfunction in preserved canine renal allografts due to humoral rejection. Am J Transplant 2004; 4: 12661273.
  • 6
    Selzner N, Rudiger H, Graf R, Clavien P-A. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917936.
  • 7
    Suzuki S, Toledo-Pereyra LH, Rodrigyez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 12651272.
  • 8
    Okajima K, Harada N, Kushimoto S, Uchiba M. Role of microthrombus formation in the development of ischemia/reperfusion—induced liver injury in rats. Thromb Haemost 2002; 88: 473480.
  • 9
    Teoh NC, Ito Y, Field J et al. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia reperfusion injury in mice. Gastroenterology 2007; (in press).
  • 10
    Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002; 62: 61326140.
  • 11
    Samarasingir DA, Tapner M, Farrell GC. Role of oxidative stress in hypoxia-reoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology 2000; 31: 160165.
  • 12
    Kuypers FA, Larkin SK, Emeis JJ, Allison AC. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost 2007; 97: 478486.
  • 13
    Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93: 6469.
  • 14
    Mullane KM, Kraemer R, Smith RB. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 4: 157167.
  • 15
    Amersi F, Shen XD, Moore C et al. Fibronectin-alpha4beta1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury. Am J Pathol 2003; 162: 12291239.
  • 16
    Anselmo AD, Amersi FF, Shen XD et al. FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration. Am J Transplant 2002; 2: 843849.
  • 17
    Ke B, Ritter T, Kato H et al. Regulatory cells potentiate the efficacy of IL-4 gene therapy by upregulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 2000; 164: 57395745.
  • 18
    Shen XD, Ke B, Zhai Y et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005; 5: 17931800.
  • 19
    Romisch J, Seiffge D, Reiner G, Pâques EP, Heimburger N. In vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb Res 1991; 61: 93104.
  • 20
    Thiagarajan P, Benedict CR. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 1997; 96: 23392347.
  • 21
    Campos B, Mo YD, Mealy TR et al. Mutational and crystallographic analyses of interfacial residues in annexin V suggest direct interactions with phospholipid membrane components. Biochemistry 1998; 37: 80048010.
  • 22
    Koopman G, Reutelingsperger CPM, Kuijten GAM et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 14151420.
  • 23
    Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. J Biol Chem 1990; 265: 1742017423.
  • 24
    Dillon SR, Mancini M, Rosen A, Schtissel MS. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol 2000; 164: 13221332.
  • 25
    Hammill AK, Uhr JW, Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic cell death. Exp Cell Res 1999; 251: 1621.
  • 26
    Neidlinger NA, Larkin SK, Bhagat A, Victorino GP, Kuypers FA. Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem 2006; 281: 775781.
  • 27
    Okusa MD, Ye H, Huang L, Sigismund L, Macdonald T, Lynch KR. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury. Am J Physiol 2003; 285: 565574.
  • 28
    Henn V, Slupsky JR, Gräfe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591594.
  • 29
    Hoffmann SC, Kampen RL, Amur S et al. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002; 74: 916923.
  • 30
    La M, Tailor A, D'Amico M, Flower RJ, Perretti M. Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: Focus on neutrophil recruitment. Eur J Pharmacol 2001; 429: 263278.
  • 31
    Shen XD, Ke B, Zhai Y et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296303.
  • 32
    Zhai Y, Shen HD, Hancock WW et al. CXCR3 +CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury. J Immunol 2006; 176: 63136322.
  • 33
    Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: A Kupffer cell mediated injury. FASEB J 2001; 15: 12301232.
  • 34
    Gujral JS, Bucci TJ, Farhood A, Jaescuki J. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis? Hepatology 2001; 33: 397405.
  • 35
    Reddien PW, Cameron S, Horvitz HR. Phagocytosis promotes programmed cell death in C. elegans. Nature 2001; 412: 198202.
  • 36
    Lang RA, Bishop JM. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 1993; 74: 453462.
  • 37
    Bilbao G, Contreras JL, Eckhoff DE et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 1999; 230: 185193.